Connect with us

International

Restrictions On Ivermectin Dropped In Australia

Restrictions On Ivermectin Dropped In Australia

Authored by Jessie Zhang via The Epoch Times (emphasis ours),

Australian medical practitioners…

Published

on

Restrictions On Ivermectin Dropped In Australia

Authored by Jessie Zhang via The Epoch Times (emphasis ours),

Australian medical practitioners can now prescribe ivermectin for COVID-19 among other diseases under new rules confirmed by the nation’s therapeutic goods authority.

Australia backsteps its stance on the effect of ivermectin on COVID-19. (Natasha Holt/The Epoch Times)

The Therapeutic Goods Administration (TGA) announced on May 3 that the prescribing of oral ivermectin will no longer be limited to specialists such as dermatologists, gastroenterologists, and infectious diseases specialists.

The move—which takes effect from June 1, 2023—comes amid high rates of vaccination and hybrid immunity against COVID-19 in Australia and thus the use of ivermectin by individuals is unlikely to now compromise public health, the TGA said in a statement.

Despite ivermectin being regularly administered in countries including India, Brazil, and Africa, TGA said that approved vaccines and treatments should still be the preferred choice due to most studies showing that ivermectin is not a useful medicine for COVID-19.

A woman holds a box of ivermectin in Brasilia, Brazil. (Andressa Anholete/Getty Images)

“A large number of clinical studies have demonstrated ivermectin does not improve outcomes in patients with COVID-19,” the TGA statement said.

“The National Covid Evidence Taskforce (NCET) and many similar bodies around the world, including the World Health Organization, strongly advises against the use of ivermectin for the prevention or treatment of COVID-19.”

The Pharmacy Guild of Australia even wrote to the panel and advised against removing the Appendix D entry relating to ivermectin because they think that if the treatment is available, people may choose not to get vaccinated.

However, after weighing all risks, the TGA concluded that restrictions should still be removed.

“The risk of medical professionals prescribing ivermectin at higher doses, or for use against COVID-19, is low given the overwhelming evidence against ivermectin use for this indication,” TGA stated.

Drug Banned Because It Was a Threat to Vaccination Uptake

Australia banned general practitioners from prescribing ivermectin in Sep. 2021.

“The concern was the likelihood that persons prescribed the drug for COVID-19 would believe themselves protected and would not get vaccinated, and would not seek the appropriate medical care if symptoms developed,” the notice of the final decision by TGA said.

“This would pose a significant risk to the community through the spread of the disease as well as the risks to individuals using ivermectin for this purpose.”

A person receives a COVID-19 vaccine at Los Angeles International Airport in Los Angeles, Calif., on Dec. 22, 2021. (Frederic J. Brown/AFP via Getty Images)

They said that ivermectin was being advocated for use in “unreliable social media posts,” increasing the risk of overdose and misuse.

Additionally, they argued that there were national shortages, although little detail was provided about the supply issues in Australia or in other countries. India even reported an excess production capacity of 23 million units a month of ivermectin.

Study Finds Ivermectin Kills COVID-19

However, in a peer-reviewed study by Monash University in Australia, published in April 2020, it was demonstrated that ivermectin could eliminate SARS-Covid-19-2 in cells in 48 hours.

The team, who have been researching ivermectin for over ten years with different viruses, discovered that a dose of ivermectin could stop the SARS-CoV-2 virus from growing in cells.

“We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours, there was a really significant reduction in it,” senior research fellow and lead study author Kylie Wagstaff said.

“Ivermectin is very widely used and seen as a safe drug,” Wagstaff said.

The U.S. Food and Drug Administration has warned against taking ivermectin for COVID-19, because it is “horse medication.” However, ivermectin packaged for human use (as shown here) has been widely prescribed for decades for a range of maladies, including for treatment of lice, other parasites and viruses. (Nanette Holt/The Epoch Times)

 The scientists said that the FDA-approved anti-parasitic drug has also been shown to be effective in vitro against a broad range of viruses, including HIV, Dengue, Influenza, and Zika virus.

They started investigating whether it worked on the COVID-19 virus as soon as the pandemic was known to have started.

However, the researchers announced a year later that they had paused their work due to insufficient sample size despite securing funding for clinical trials.

The low numbers of COVID cases in Australia in 2020 meant the planned trial in Australia had to be paused,” the Monash University laboratory said in an ivermectin research progress update in Aug. 2021.

“The establishment of a trial depends on Australian and overseas circumstances and will be communicated when we are in a position to do so.”

Industry Incentives Under Scrutiny

Meanwhile, pharmaceutical authorities around the world are under growing scrutiny over the funding many receive from the industry itself, with an investigation revealing that half of their funding comes from the pharmaceutical industry—the industry they are supposed to be regulating.

In a report, published in the British Journal of Medicine, it was discovered that the U.S. FDA receives 65 percent of its funding from the pharmaceutical industry, the MHRA (UK) receives 86 percent, and the Australian TGA receives 96 percent of its funding from the pharmaceutical industry.

Additionally, award-winning investigative journalist Maryanne Demasi found in the report that the TGA approved 94 percent of all applications between 2020 to 2021.

She filed for FOIA report to get disclosures on the TGA committee members who had conflicts of interest in their approval of the mRNA vaccines, but the TGA allegedly redacted the identity of these members, highlighting that it was personal information.

Comparing major drug regulators on conflicts of interest, according to data by Maryanne Demasi (The Epoch Times)

The final decision to remove restrictions on ivermectin prescriptions followed an application to remove the rules, according to the process required under the Therapeutic Goods Act 1989.

It also took into account advice from an independent advisory committee on the scheduling of medicines and two rounds of public consultations.

Tyler Durden Thu, 05/04/2023 - 22:00

Read More

Continue Reading

International

There will soon be one million seats on this popular Amtrak route

“More people are taking the train than ever before,” says Amtrak’s Executive Vice President.

Published

on

While the size of the United States makes it hard for it to compete with the inter-city train access available in places like Japan and many European countries, Amtrak trains are a very popular transportation option in certain pockets of the country — so much so that the country’s national railway company is expanding its Northeast Corridor by more than one million seats.

Related: This is what it's like to take a 19-hour train from New York to Chicago

Running from Boston all the way south to Washington, D.C., the route is one of the most popular as it passes through the most densely populated part of the country and serves as a commuter train for those who need to go between East Coast cities such as New York and Philadelphia for business.

Veronika Bondarenko captured this photo of New York’s Moynihan Train Hall. 

Veronika Bondarenko

Amtrak launches new routes, promises travelers ‘additional travel options’

Earlier this month, Amtrak announced that it was adding four additional Northeastern routes to its schedule — two more routes between New York’s Penn Station and Union Station in Washington, D.C. on the weekend, a new early-morning weekday route between New York and Philadelphia’s William H. Gray III 30th Street Station and a weekend route between Philadelphia and Boston’s South Station.

More Travel:

According to Amtrak, these additions will increase Northeast Corridor’s service by 20% on the weekdays and 10% on the weekends for a total of one million additional seats when counted by how many will ride the corridor over the year.

“More people are taking the train than ever before and we’re proud to offer our customers additional travel options when they ride with us on the Northeast Regional,” Amtrak Executive Vice President and Chief Commercial Officer Eliot Hamlisch said in a statement on the new routes. “The Northeast Regional gets you where you want to go comfortably, conveniently and sustainably as you breeze past traffic on I-95 for a more enjoyable travel experience.”

Here are some of the other Amtrak changes you can expect to see

Amtrak also said that, in the 2023 financial year, the Northeast Corridor had nearly 9.2 million riders — 8% more than it had pre-pandemic and a 29% increase from 2022. The higher demand, particularly during both off-peak hours and the time when many business travelers use to get to work, is pushing Amtrak to invest into this corridor in particular.

To reach more customers, Amtrak has also made several changes to both its routes and pricing system. In the fall of 2023, it introduced a type of new “Night Owl Fare” — if traveling during very late or very early hours, one can go between cities like New York and Philadelphia or Philadelphia and Washington. D.C. for $5 to $15.

As travel on the same routes during peak hours can reach as much as $300, this was a deliberate move to reach those who have the flexibility of time and might have otherwise preferred more affordable methods of transportation such as the bus. After seeing strong uptake, Amtrak added this type of fare to more Boston routes.

The largest distances, such as the ones between Boston and New York or New York and Washington, are available at the lowest rate for $20.

Read More

Continue Reading

International

The next pandemic? It’s already here for Earth’s wildlife

Bird flu is decimating species already threatened by climate change and habitat loss.

I am a conservation biologist who studies emerging infectious diseases. When people ask me what I think the next pandemic will be I often say that we are in the midst of one – it’s just afflicting a great many species more than ours.

I am referring to the highly pathogenic strain of avian influenza H5N1 (HPAI H5N1), otherwise known as bird flu, which has killed millions of birds and unknown numbers of mammals, particularly during the past three years.

This is the strain that emerged in domestic geese in China in 1997 and quickly jumped to humans in south-east Asia with a mortality rate of around 40-50%. My research group encountered the virus when it killed a mammal, an endangered Owston’s palm civet, in a captive breeding programme in Cuc Phuong National Park Vietnam in 2005.

How these animals caught bird flu was never confirmed. Their diet is mainly earthworms, so they had not been infected by eating diseased poultry like many captive tigers in the region.

This discovery prompted us to collate all confirmed reports of fatal infection with bird flu to assess just how broad a threat to wildlife this virus might pose.

This is how a newly discovered virus in Chinese poultry came to threaten so much of the world’s biodiversity.

H5N1 originated on a Chinese poultry farm in 1997. ChameleonsEye/Shutterstock

The first signs

Until December 2005, most confirmed infections had been found in a few zoos and rescue centres in Thailand and Cambodia. Our analysis in 2006 showed that nearly half (48%) of all the different groups of birds (known to taxonomists as “orders”) contained a species in which a fatal infection of bird flu had been reported. These 13 orders comprised 84% of all bird species.

We reasoned 20 years ago that the strains of H5N1 circulating were probably highly pathogenic to all bird orders. We also showed that the list of confirmed infected species included those that were globally threatened and that important habitats, such as Vietnam’s Mekong delta, lay close to reported poultry outbreaks.

Mammals known to be susceptible to bird flu during the early 2000s included primates, rodents, pigs and rabbits. Large carnivores such as Bengal tigers and clouded leopards were reported to have been killed, as well as domestic cats.

Our 2006 paper showed the ease with which this virus crossed species barriers and suggested it might one day produce a pandemic-scale threat to global biodiversity.

Unfortunately, our warnings were correct.

A roving sickness

Two decades on, bird flu is killing species from the high Arctic to mainland Antarctica.

In the past couple of years, bird flu has spread rapidly across Europe and infiltrated North and South America, killing millions of poultry and a variety of bird and mammal species. A recent paper found that 26 countries have reported at least 48 mammal species that have died from the virus since 2020, when the latest increase in reported infections started.

Not even the ocean is safe. Since 2020, 13 species of aquatic mammal have succumbed, including American sea lions, porpoises and dolphins, often dying in their thousands in South America. A wide range of scavenging and predatory mammals that live on land are now also confirmed to be susceptible, including mountain lions, lynx, brown, black and polar bears.

The UK alone has lost over 75% of its great skuas and seen a 25% decline in northern gannets. Recent declines in sandwich terns (35%) and common terns (42%) were also largely driven by the virus.

Scientists haven’t managed to completely sequence the virus in all affected species. Research and continuous surveillance could tell us how adaptable it ultimately becomes, and whether it can jump to even more species. We know it can already infect humans – one or more genetic mutations may make it more infectious.

At the crossroads

Between January 1 2003 and December 21 2023, 882 cases of human infection with the H5N1 virus were reported from 23 countries, of which 461 (52%) were fatal.

Of these fatal cases, more than half were in Vietnam, China, Cambodia and Laos. Poultry-to-human infections were first recorded in Cambodia in December 2003. Intermittent cases were reported until 2014, followed by a gap until 2023, yielding 41 deaths from 64 cases. The subtype of H5N1 virus responsible has been detected in poultry in Cambodia since 2014. In the early 2000s, the H5N1 virus circulating had a high human mortality rate, so it is worrying that we are now starting to see people dying after contact with poultry again.

It’s not just H5 subtypes of bird flu that concern humans. The H10N1 virus was originally isolated from wild birds in South Korea, but has also been reported in samples from China and Mongolia.

Recent research found that these particular virus subtypes may be able to jump to humans after they were found to be pathogenic in laboratory mice and ferrets. The first person who was confirmed to be infected with H10N5 died in China on January 27 2024, but this patient was also suffering from seasonal flu (H3N2). They had been exposed to live poultry which also tested positive for H10N5.

Species already threatened with extinction are among those which have died due to bird flu in the past three years. The first deaths from the virus in mainland Antarctica have just been confirmed in skuas, highlighting a looming threat to penguin colonies whose eggs and chicks skuas prey on. Humboldt penguins have already been killed by the virus in Chile.

A colony of king penguins.
Remote penguin colonies are already threatened by climate change. AndreAnita/Shutterstock

How can we stem this tsunami of H5N1 and other avian influenzas? Completely overhaul poultry production on a global scale. Make farms self-sufficient in rearing eggs and chicks instead of exporting them internationally. The trend towards megafarms containing over a million birds must be stopped in its tracks.

To prevent the worst outcomes for this virus, we must revisit its primary source: the incubator of intensive poultry farms.

Diana Bell does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

International

This is the biggest money mistake you’re making during travel

A retail expert talks of some common money mistakes travelers make on their trips.

Published

on

Travel is expensive. Despite the explosion of travel demand in the two years since the world opened up from the pandemic, survey after survey shows that financial reasons are the biggest factor keeping some from taking their desired trips.

Airfare, accommodation as well as food and entertainment during the trip have all outpaced inflation over the last four years.

Related: This is why we're still spending an insane amount of money on travel

But while there are multiple tricks and “travel hacks” for finding cheaper plane tickets and accommodation, the biggest financial mistake that leads to blown travel budgets is much smaller and more insidious.

A traveler watches a plane takeoff at an airport gate.

Jeshoots on Unsplash

This is what you should (and shouldn’t) spend your money on while abroad

“When it comes to traveling, it's hard to resist buying items so you can have a piece of that memory at home,” Kristen Gall, a retail expert who heads the financial planning section at points-back platform Rakuten, told Travel + Leisure in an interview. “However, it's important to remember that you don't need every souvenir that catches your eye.”

More Travel:

According to Gall, souvenirs not only have a tendency to add up in price but also weight which can in turn require one to pay for extra weight or even another suitcase at the airport — over the last two months, airlines like Delta  (DAL) , American Airlines  (AAL)  and JetBlue Airways  (JBLU)  have all followed each other in increasing baggage prices to in some cases as much as $60 for a first bag and $100 for a second one.

While such extras may not seem like a lot compared to the thousands one might have spent on the hotel and ticket, they all have what is sometimes known as a “coffee” or “takeout effect” in which small expenses can lead one to overspend by a large amount.

‘Save up for one special thing rather than a bunch of trinkets…’

“When traveling abroad, I recommend only purchasing items that you can't get back at home, or that are small enough to not impact your luggage weight,” Gall said. “If you’re set on bringing home a souvenir, save up for one special thing, rather than wasting your money on a bunch of trinkets you may not think twice about once you return home.”

Along with the immediate costs, there is also the risk of purchasing things that go to waste when returning home from an international vacation. Alcohol is subject to airlines’ liquid rules while certain types of foods, particularly meat and other animal products, can be confiscated by customs. 

While one incident of losing an expensive bottle of liquor or cheese brought back from a country like France will often make travelers forever careful, those who travel internationally less frequently will often be unaware of specific rules and be forced to part with something they spent money on at the airport.

“It's important to keep in mind that you're going to have to travel back with everything you purchased,” Gall continued. “[…] Be careful when buying food or wine, as it may not make it through customs. Foods like chocolate are typically fine, but items like meat and produce are likely prohibited to come back into the country.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

Trending